Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Cash & Equivalents (2018 - 2025)

Inventiva (IVEVF) posted Cash & Equivalents of $115.6 million for Q4 2025, down 16.34% on a QoQ basis from $138.2 million in Q2 2025, and up 12.03% year-over-year from $103.2 million in Q4 2024.

Analysis

Inventiva (IVEVF) Cash & Equivalents (2018 - 2025) Analysis & Trends

Inventiva has reported Cash & Equivalents for 8 years, with the latest figure at $115.6 million in Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 12.03% year-over-year to $115.6 million in Q4 2025; TTM through Dec 2025 was $115.6 million, a 12.03% increase from a year earlier, with the FY2025 full-year figure at $115.6 million, up 12.03% from the prior year.
  • Cash & Equivalents was $115.6 million for Q4 2025 at Inventiva, down from $138.2 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $138.2 million in Q2 2025, with the low at $10.9 million in Q2 2024.
  • Average Cash & Equivalents over 5 years is $85.7 million, with a median of $99.0 million recorded in 2021.
  • The sharpest annual moves came in 2024 and 2025: Cash & Equivalents tumbled 67.88% in 2024, then soared 1164.6% in 2025.
  • Over 5 years, Cash & Equivalents stood at $99.0 million in 2021, then retreated by 10.63% to $88.5 million in 2022, then plunged by 67.27% to $29.0 million in 2023, then surged by 256.29% to $103.2 million in 2024, then advanced by 12.03% to $115.6 million in 2025.
  • The last three Cash & Equivalents figures came in at $115.6 million (Q4 2025), $138.2 million (Q2 2025), and $103.2 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn 20.42 Bn
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn 6.57 Bn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn 6.85 Bn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn 7.62 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 976.00 Mn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 7.38 Bn
7 Revolution Medicines 44.23 Bn 44.23 Bn - 815.44 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 3.98 Bn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 1.80 Bn
10 Inventiva 693.72 Mn 693.72 Mn - 115.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 115.60 Mn
Jun 30, 2025 138.19 Mn
Dec 31, 2024 103.19 Mn
Jun 30, 2024 10.93 Mn
Dec 31, 2023 28.96 Mn
Jun 30, 2023 34.02 Mn
Dec 31, 2022 88.49 Mn
Jun 30, 2022 81.53 Mn
Dec 31, 2021 99.01 Mn
Jun 30, 2021 112.76 Mn
Mar 31, 2021 130.04 Mn
Dec 31, 2020 126.01 Mn
Jun 30, 2020 57.58 Mn
Dec 31, 2019 39.67 Mn
Dec 31, 2018 64.71 Mn